§ 13F · FUND PROFILE

GSK plc.

Institutional filer · behavioral pattern: Other. Summary pending.
AUM · (13F)Positions · 13Turnover · · Q1Filed · May 14, 2026
CONCENTRATION
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
No prior quarter data
3YR HIT RATE
Top-5 overlap
§ 01 · TOP HOLDINGS

The book · Q1 2026

FILED MAY 14, 2026
#TickerNameShares$ value% portΔ Q1
1CRSPCRISPR THERAPEUTICS AG3.22M$153M25.6%±0%
2WVEWAVE LIFE SCIENCES LTD18.25M$132M22.1%±0%
3BNTXBIONTECH SE890K$79M13.2%±0%
4VIRVIR BIOTECHNOLOGY INC8.55M$77M12.8%±0%
5IDYAIDEAYA BIOSCIENCES INC1.33M$44M7.4%±0%
6LYELLYELL IMMUNOPHARMA INC1.51M$30M5.1%±0%
7CYTKCYTOKINETICS INC340K$22M3.7%±0%
8SPROSPERO THERAPEUTICS INC9.19M$22M3.6%±0%
9FULCFULCRUM THERAPEUTICS INC1.79M$14M2.3%±0%
10CVRXCVRX INC1.01M$10M1.6%±0%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE GSK SIGNAL

AC read

GSK plc is classified as a Other fund.

Read the full dossier →
§ 04 · FILING HISTORY

Q-by-Q deltas

1 FILINGS
Q1 2026
Steady book
+0 buys · 0 exits · 0 changed
Q4 2025
Steady book
+0 buys · 0 exits · 0 changed